UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 2, 2013

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-30941

 

34-1818596

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts

 

01915

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (978) 787-4000

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02 Results of Operations and Financial Condition

 

On May 2, 2013, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for the three months ended March 31, 2013.  The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01   Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated May 2, 2013. Filed herewith.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 2, 2013

Axcelis Technologies, Inc.

 

 

 

 

By:

/s/ JAY ZAGER

 

 

Jay Zager

 

 

Executive Vice President

 

 

and Chief Financial Officer

 

3


Exhibit 99.1

 

GRAPHIC

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER 2013

 

BEVERLY, Mass. — May 2, 2013—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the quarter ended March 31, 2013. The Company reported first quarter revenue of $40.7 million, compared to $44.6 million for the fourth quarter of 2012. Net loss for the quarter was $9.0 million, or $(0.08) per share, which includes:  a $0.4 million milestone payment from the dry strip asset sale to Lam Research Corporation; a $2.1 million charge associated with an inventory write off of 300mm dry strip production components; and $1.8 million of restructuring charges.  This compares to a net loss for the fourth quarter of 2012 of $14.8 million, or ($0.14) per share, which included:  a $7.9 million gain from the dry strip asset sale to Lam Research; a $13.4 million charge associated with an inventory write off; and $0.6 million of restructuring charges. Cash and cash equivalents were $42.4 million at March 31, 2013 compared with $45.0 million at December 31, 2012.

 

Chairman and CEO Mary Puma said, “During the quarter our Purion M medium current ion implanter was selected for evaluation by two new customers, representing both memory and foundry market segments. Earlier this week we announced the introduction of the Purion XE, a high energy ion implanter, the second member of our Purion platform family.  Our Purion platform is the foundation for all future generation Axcelis implanters. Purion products are key to our future success and will allow us to quickly capitalize on improving market conditions.”

 

Ms. Puma added, “Each member of the Purion family shares a common, powerful 500+ wafers per hour single wafer end station, industry leading source technology and an innovative and productive ultra-pure beam line. The Purion platform was developed in response to customer requirements for absolute beam purity and the most precise dopant placement possible, while ensuring the highest levels of productivity and capital efficiency.  The Purion platform redefines next generation implanter technology and performance and enables the efficient production of leading edge semiconductor devices.”

 

First Quarter 2013 Conference Call

 

The Company will host a conference call today at 5:00 pm ET to discuss results for the first quarter of 2013.  An audio webcast will be available on the Investor page of Axcelis’ website at www.axcelis.com, or by dialing 1.888.680.0878 (1.617.213.4855 outside North America).  Participants calling into the conference call will be requested to provide the passcode:  43640965. A replay of the webcast will be available for 30 days following the conference call.

 

1



 

Safe Harbor Statement

 

The conference call will contain forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis

 

Axcelis Technologies, Inc. (Nasdaq: ACLS) headquartered in Beverly, Massachusetts, has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, one of the most critical and enabling steps in the IC manufacturing process.  The Company’s Internet address is: www.axcelis.com.

 

Company Contacts

 

Financial Community:

Jay Zager
978.787.9408

 

Editorial/Media Community:

Maureen Hart
978.787.4266

 

2



 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three months ended
March 31,

 

 

 

2013

 

2012

 

Revenue

 

 

 

 

 

Product

 

$

34,452

 

$

47,538

 

Services

 

6,274

 

7,468

 

Total revenue

 

40,726

 

55,006

 

Cost of revenue

 

 

 

 

 

Product

 

22,181

 

29,284

 

Services

 

5,602

 

5,186

 

Total cost of revenue

 

27,783

 

34,470

 

 

 

 

 

 

 

Gross profit

 

12,943

 

20,536

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

Research and development

 

9,206

 

11,669

 

Sales and marketing

 

5,201

 

6,583

 

General and administrative

 

6,590

 

7,799

 

Gain on sale of dry strip assets and intellectual property

 

(368

)

 

Restructuring charges

 

1,801

 

2,881

 

Total operating expenses

 

22,430

 

28,932

 

 

 

 

 

 

 

Loss from operations

 

(9,487

)

(8,396

)

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

Interest income

 

3

 

9

 

Other, net

 

829

 

(924

)

Total other income (expense)

 

832

 

(915

)

 

 

 

 

 

 

Loss before income taxes

 

(8,655

)

(9,311

)

 

 

 

 

 

 

Income taxes

 

333

 

717

 

 

 

 

 

 

 

Net loss

 

$

(8,988

)

$

(10,028

)

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

Basic and Diluted

 

$

(0.08

)

$

(0.09

)

 

 

 

 

 

 

Shares used in computing net loss per share

 

 

 

 

 

Basic and diluted weighted average common shares

 

108,227

 

107,067

 

 

3



 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

 

 

March 31,
2013

 

December 31,
2012

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

42,441

 

$

44,986

 

Accounts receivable, net

 

23,150

 

24,843

 

Inventories, net

 

98,729

 

100,234

 

Restricted cash

 

103

 

106

 

Prepaid expenses and other current assets

 

5,519

 

5,056

 

Total current assets

 

169,942

 

175,225

 

 

 

 

 

 

 

Property, plant and equipment, net

 

33,663

 

34,413

 

Other assets

 

12,352

 

12,520

 

Total assets

 

$

215,957

 

$

222,158

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

13,793

 

$

10,166

 

Accrued compensation

 

8,900

 

7,283

 

Warranty

 

1,539

 

1,700

 

Income taxes

 

356

 

278

 

Deferred revenue

 

5,714

 

6,423

 

Other current liabilities

 

3,768

 

3,932

 

Total current liabilities

 

34,070

 

29,782

 

 

 

 

 

 

 

Long-term deferred revenue

 

321

 

456

 

Other long-term liabilities

 

5,713

 

5,844

 

Total liabilities

 

40,104

 

36,082

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred stock, $0.001 par value, 30,000 shares authorized; none issued or outstanding

 

 

 

Common stock, $0.001 par value, 300,000 shares authorized; 108,405 shares issued and 108,285 shares outstanding at March 31, 2013;108,293 shares issued and 108,173 shares outstanding at December 31, 2012

 

108

 

108

 

Additional paid-in capital

 

505,478

 

504,643

 

Treasury stock, at cost, 120 shares at March 31, 2013 and December 31, 2012

 

(1,218

)

(1,218

)

Accumulated deficit

 

(331,465

)

(322,477

)

Accumulated other comprehensive income

 

2,950

 

5,020

 

Total stockholders’ equity

 

175,853

 

186,076

 

Total liabilities and stockholders’ equity

 

$

215,957

 

$

222,158

 

 

4



 

Axcelis Technologies, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2013

 

2012

 

Cash flows from operating activities

 

 

 

 

 

Net loss

 

$

(8,988

)

$

(10,028

)

Adjustments to reconcile net loss to net cash used for operating activities:

 

 

 

 

 

Depreciation and amortization

 

1,394

 

1,896

 

Gain on sale of dry strip assets and intellectual property

 

(368

)

 

Deferred taxes

 

56

 

378

 

Stock-based compensation expense

 

839

 

1,082

 

Provision for excess inventory

 

2,211

 

248

 

Changes in operating assets & liabilities

 

 

 

 

 

Accounts receivable

 

1,458

 

4,810

 

Inventories

 

(1,672

)

(8,277

)

Prepaid expenses and other current assets

 

(544

)

(385

)

Accounts payable and other current liabilities

 

5,043

 

(2,162

)

Deferred revenue

 

(843

)

(3,818

)

Income taxes

 

84

 

76

 

Other assets and liabilities

 

(549

)

6,483

 

Net cash used for operating activities

 

(1,879

)

(9,697

)

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Proceeds from sale of dry strip assets and intellectual property

 

400

 

 

Expenditures for property, plant, and equipment

 

(150

)

(141

)

(Increase) decrease in restricted cash

 

3

 

(3

)

Net cash provided by (used for) investing activities

 

253

 

(144

)

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Proceeds from exercise of stock options

 

49

 

802

 

Proceeds from Employee Stock Purchase Plan

 

 

175

 

Net cash provided by financing activities

 

49

 

977

 

Effect of exchange rate changes on cash

 

(968

)

(795

)

Net decrease in cash and cash equivalents

 

(2,545

)

(9,659

)

Cash and cash equivalents at beginning of period

 

44,986

 

46,877

 

Cash and cash equivalents at end of period

 

$

42,441

 

$

37,218

 

 

5